OncoCyte Profit Margin

As of the most recent data (March 2026), 0KCC.L shows a profit margin of -2454.64%. That compares with -1514.57% in the prior-year period — down 62.1% year over year. That is below the sector sector average of 19.61%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 0KCC.L's profit margin is now -2454.64% (was -1514.57%) — a 62.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether OncoCyte is outperforming or lagging.

The its sector sector average profit margin is about 19.61%. OncoCyte is at -2454.64%, which is lower that average. That is roughly 12619.4% below the sector mean. Use the comparison chart on this page to see how 0KCC.L stacks up against individual peers as well.

That compares with -1514.57% in the prior-year period — down 62.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare OncoCyte with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has OncoCyte's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -2454.64%) with ownership activity and broader fundamentals.